Kent Lake Pr LLC Myriad Genetics Inc Transaction History
Kent Lake Pr LLC
- $227 Billion
- Q2 2025
A detailed history of Kent Lake Pr LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Kent Lake Pr LLC holds 1,250,000 shares of MYGN stock, worth $9.99 Million. This represents 2.93% of its overall portfolio holdings.
Number of Shares
1,250,000Holding current value
$9.99 Million% of portfolio
2.93%Shares
1 transactions
Others Institutions Holding MYGN
# of Institutions
234Shares Held
94.2MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$121 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$74 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$39.3 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$38.4 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$36.7 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $644M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...